DCA Vantage® Analyzer
Drive diabetic patient compliance with trusted, clinically proven results
DCA Vantage Analyzer
Watch animation
Actionable results in 7 minutes or less
Minimize the need for follow-up visits with a full spectrum of results: HbA1c (NGSP certified and IFCC certified/CLIA waived), Estimated Average Glucose*, Albumin, Creatinine, and Albumin-to-Creatinine Ratio results.
*Not available in the US
Easy to use in the office or clinic
No sample or reagent preparation is required, and the system provides versatile data management and reporting options
Robust technology delivers proven performance
The analyzer leverages robust technology and delivers the proven performance of the DCA HbA1c and DCA Microalbumin/Creatinine tests highlighted in more than 140 clinical articles.
Manage diabetes testing in decentralized settings
Powerful functionality enables POC coordinators to better manage diabetes testing in decentralized settings. When supported by Siemens RAPIDComm® Data Management System, coordinators can oversee and troubleshoot multiple connected analyzers in real time.
Provide the clinical confidence your patients deserve. The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s office to remote, point-of-care coordinated sites in hospitals and multisite practices. Meet lab-quality testing standards with an analyzer that speeds and simplifies diabetes tests and delivers accurate,1 clinically relevant results shown to improve decision-making,2,3 patient compliance, and outcomes.4
Compartir esta página:
Productos, servicios y recursos relacionados
References
1. Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.
2. Thaler LM, et al. Diabetes Care 1999;22:1415-21.
3. Miller CD, et al. Diabetes Care 2003;26:1158-63.
4. Cagliero E, et al. Diabetes Care 1999;22:1785-9.
5. GHX Market Intelligence, market data report. 4Q 2012 Report.